Moreover, the FXR agonist GW4064 can reduce estradiol-induced cholestasis in liver cells (Seok et al., 2014) to increase uptake of bile salts, restore the flow of bile and reduce the levels of serum bile salt. This evidence concerns the gene NR1H4 and cholestasis.